Abstract
A 71-year-old man developed severe limb, bulbar, and respiratory weakness over 18 months. A muscle biopsy showed only a moderate degree of type 2 atrophy, but immunocytochemistry showed absence of chondroitin sulfate C glycosaminoglycan in the endomysium. Prednisone produced a marked increase in strength. Diffuse loss of endomysial chondroitin sulfate C was a feature of this treatable myopathy with severe weakness, but few pathologic changes.
Original language | English |
---|---|
Pages (from-to) | 526-529 |
Number of pages | 4 |
Journal | Neurology |
Volume | 50 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1998 |